Here we describe the creation of three integration vectors, pPEPX, pPEPY and pPEPZ, for use with the opportunistic human pathogen Streptococcus pneumoniae. The constructed vectors, named PEP for Pneumococcal Engineering Platform, employ an IPTG-inducible promoter and BglBrick and BglFusion compatible multiple cloning sites allowing for fast and interchangeable cloning. PEP plasmids replicate in Escherichia coli and harbor integration sites that have homology in a large set of pneumococcal strains, including recent clinical isolates. In addition, several options of antibiotic resistance markers are available, even allowing for selection in multidrug resistant clinical isolates. The transformation efficiency of these PEP vectors as well as their ability to be expressed simultaneously were tested. Two of the three PEP vectors share homology of the integration regions with over half of the S. pneumoniae genomes examined. Transformation efficiency varied among PEP vectors based on the length of the homology regions, but all were highly transformable and can be integrated simultaneously in strain D39V. Vectors used for pneumococcal cloning are an important tool for researchers for a wide range of uses. The PEP vectors described are of particular use because they have been designed to allow for easy transfer of genes between vectors as well as integrating into transcriptionally silent areas of the chromosome. In addition, we demonstrate the successful production of several new spectrally distinct fluorescent proteins (mTurquoise2, mNeonGreen and mScarlet-I) from the PEP vectors. The PEP vectors and newly described fluorescent proteins will expand the genetic toolbox for pneumococcal researchers and aid future discoveries.
Introduction
Infectious disease is one of the most common causes of death worldwide and is an object of intense scientific study (1) . A powerful tool into the research of human pathogens is the ability to manipulate the pathogen in a desired manner to observe the outcome. These manipulations can take many forms; gene deletions, genetic complementation, gene mutations, or controlled expression. To aid in alteration of a target genome, numerous methods have been developed over the years with varying success depending on the targeted pathogen (2) . Tool development in model organisms tend to be over represented compared to other species, with bacterial human pathogens having fewer options. While the study of model organisms has led to great advances in understanding the nature of diverse bacterial functions, they are not useful for pathogen specific processes. In an attempt to ameliorate this deficit, we set out to develop several cloning vectors useful for genetic manipulation in Streptococcus pneumoniae, even in recent clinically relevant isolates.
The bacterium S. pneumoniae is an important opportunistic human pathogen that is responsible for over a million deaths per annum (3) . S. pneumoniae has been extensively studied in the past decades and several useful tools for genetic manipulation have been created that allow for stable single copy integration at the genome. However, there is still a lack of robust suicide vectors that do not disrupt native expression of important genes that can be combined to insert several genes in the same strain or can be applied to multi-drug resistant clinical isolates. One of the most commonly used ectopic integration site in S. pneumoniae is the bgaA locus (4-7), that thereby disrupts this beta-galactosidase, which might have an important function during colonization of human epithelial cells (8) (9) (10) . The only neutral integration site for which integration plasmids have been developed is the CEP locus, which is a transcriptionally silent site within a truncated IS 1167 element downstream of the well-studied ami operon (11, 12) . However, this locus is not very well conserved among pneumococcal strains (see below).
Utilizing extensive RNA-seq data for S. pneumoniae in multiple conditions (13) , transcriptionally silent regions were identified for potential chromosomal locations to use as recombination sites. Using the pneumococcal engineering platform (PEP) vector as a guide (12) , novel integration vectors were developed for use at these regions. In this study, we have developed and tested three new PEP vectors, pPEPX, pPEPY, and pPEPZ, for their ability to be transformed into S. pneumoniae, compatibility for co-expression, and frequency of occurrence in pneumococcal isolates. In addition, three spectrally distinct and intrinsically bright fluorescent proteins, mTurquoise2, mNeonGreen and mScarlet-I, were added to the fluorescence protein toolbox now available for S. pneumoniae.
Results

Design and construction of pPEPX, pPEPY and pPEPZ
As seen in Figure 1 , the three pneumococcal engineering platform plasmids created have compatible cloning sites following the BglBrick and BglFusion principle (12, 27) , to facilitate easy exchange between the plasmids. The exception is in the pPEPY vector with the EcoRI site located downstream of the Plac promoter as opposed to upstream as in the other two plasmids. The integration regions vary for each vector, but are in transcriptionally silent areas of the genome as determined by RNA-seq data (13) . The pPEPX vector integrates about 295˚ around the chromosome between the treR (SPV_1665) and amiF (SPV_1666) genes (Figure 2A, B) . The pPEPY vector integrates at 75˚ around the chromosome between spv_2165 and spv_2166, both encoding hypothetical proteins, (Figure 2A, B ). The last constructed vector, pPEPZ, integrates at 304˚ around the chromosome, upstream of spv_1736, which encodes a degenerative hypothetical protein (Figure 2A , B). Transcriptional terminators flank the MCS in all vectors to ensure that the inserted DNA is not influenced by transcriptional events happening elsewhere on the chromosome. The origin of replication used for all plasmids is a high copy number E. coli origin derived from pUC18 that is not recognized by S. pneumoniae. All selective markers are expressed in both E. coli and S. pneumoniae.
Various antibiotic markers were created for pPEPZ to facilitate integration of multiple PEP vectors simultaneously, as well as providing multiple options depending on the researchers need. As pPEPZ has a large pneumococcal host range (see below), we also constructed pPEPZ variants with antibiotic resistance alleles less commonly found in clinical isolates such as trimethoprim and gentamycin ( Fig. 2) . No PEP vectors contain the tetracycline resistance marker for selection, allowing strains to utilize PEP vectors in combination with the popular pPP1/pJWV/pKB bgaA-based integration vectors (5) (6) (7) . Table 1 summarizes vectors and available resistance markers.
Vector construction was done through various cloning techniques, but common motifs were kept for all PEP vectors. These include the same origin of replication for a high copy number in E. coli, similar multiple cloning sites to facilitate rapid exchange between plasmids, an IPTG inducible promoter with tight expression control, and multiple antibiotic selection markers for use in almost any background. Expression without an inducible promoter can be done using pPEPY or standard cloning can be used to exchange the promoter Plac with any desired promoter. A list of available vectors and the selectable markers can be found in Table 1 . Note that to make use of the Plac IPTG inducible promoter (Sorg et al. in preparation) , the strain also needs to encode the LacI repressor from E. coli otherwise the promoter will be constitutively expressed. We noticed significant vector stability when leaving out the gene encoding the lacI repressor from the plasmid. Therefore we used a separate, ectopic integration of lacI (20) . This lacI construct can be obtained via Addgene (catalog #85589) and is integrated at the prs1 locus by selecting for gentamycin (20) .
High transformation efficiency of pPEPX, pPEPY and pPEPZ
Transformation efficiency of these three vectors was determined in S. pneumoniae strain D39V ( Figure 3 ). Multiple concentrations of DNA were tested and the amounts used were normalized to molar concentrations to remove concentration effects due to size differences in the plasmids. It was found that pPEPZ had higher transformation efficiencies than either pPEPX or pPEPY at all DNA concentrations tested (0.064, 0.32, 1.6, 8.0, 40.0, 200.0, 1000.0 nM), with a maximum transformation efficiency of approximately 10 -3 (0.1% of transformants per total amount of viable cells) compared to 10 -4 . This is most likely due to the longer regions of homology present on pPEPZ (1 kb) compared to the homologous integration regions present on pPEPX (500 bps) and pPEPY (500 bps). For all vectors tested there was a two-log increase in transformation efficiency from the lowest concentration (0.064 nM) of DNA added to the highest concentration (1000 nM). A rapid increase in transformation efficiency was observed upon increasing DNA concentrations, but gradually leveled off at a concentration of 40 nM of DNA for all PEP vectors. This data is completely in line with previously described transformation efficiencies in S. pneumoniae that demonstrated a similar relation between length of the homology regions and DNA concentration (28, 29) . In summary, all described vectors can be efficiently transformed into strain D39V and acquisition of one vector does not exclude integration of other PEP vectors at available integration loci. 
Simultaneous integration and expression of three new fluorescent proteins for S. pneumoniae from the pPEPX, pPEPY and pPEPZ loci
To demonstrate the feasibility to clone and construct a strain that expresses heterologous proteins from all three integration platforms simultaneously, we utilized several recent spectrally distinct fluorescent proteins not yet widely used in the pneumococcal research field, namely mTurquoise2 (22) , mNeonGreen (23), and mScarlet-I (24). To make sure these proteins do not demonstrate any spectral overlap under our experimental conditions, we fused them to genes encoding proteins with a distinct cellular localization. We cloned the genes encoding spv_1159-mScarlet-I in pPEPX, comEA-mTurquoise2 in pPEPY and hlpA-mNeonGreen in pPEPZ and then transformed them into strain D39V in serial (see M&M). Note that we directly transformed the ligation mixtures to S. pneumoniae without an intermediate E. coli clone (30) .
Expression of all fusion proteins in constructed strain VL2706 was induced by addition of 1 mM IPTG for 1 hr before visualization by fluorescence microscopy. We selected ComEA as this is a protein involved in DNA uptake and was previously shown to demonstrate a septal localization (31) . HlpA (HU) was chosen as it binds to the nucleoid and is a good marker for the chromosome (32, 33) . SPV_1159 was selected as it is a predicted small membrane protein with two transmembrane domains with both the N-and C-terminus inside the cytoplasm and was previously shown to demonstrate homogenous membrane localization in our laboratory (Gallay and Veening, unpublished). As shown in Figure 4 , cellular morphology of this triple labelled strain is indistinguishable from wild type and we obtained clear, distinguishable fluorescent signals for all three fusion proteins. In addition, all fusions demonstrated their predicted localization. Also, growth curves of parent strain D39V and VL2706 were indistinguishable after 12 hrs of growth (Supp. Figure 1 ). This demonstrates that stable integration and simultaneous expression of heterologous proteins from pPEPX, pPEPY, and pPEPZ is possible, and provides a new set of fluorescent proteins for use in S. pneumoniae.
Broad pneumococcal strain range for pPEPY and pPEPZ
All vectors were designed and based on the genome and transcription data of S. pneumoniae strain D39V (13, 14, 34) . To determine if the constructed vectors can be used in multiple strains of S. pneumoniae as well as closely related species, whole genome sequences were queried for the integrative regions of the PEP vectors. All genomes from NCBI at contig level or above were downloaded for S. pneumoniae (2,875 strains), S. pseudopneumoniae (38 strains), S. tigurinus (19 strains), S. mutans (190 strains), S. equi (259 strains), S. pyogenes (449 strains), and S. suis (1,261 strains). Additional genomes for S. pneumoniae were obtained from the Maela database (35) (3,085 strains) for a total of 5,960 pneumococcal genomes. Only 5,029 pneumococcal genomes were tested due to duplication of some sequences between the two databases ( Figure  5 ). A positive hit for the strain was determined when both integrative regions with a homology of at least 95% were present and had at least 90% of the total integration region. The pPEPX vector passed these A) D39V chromosome with all positive strand genes (yellow), negative strand genes (green), and labeled integration loci. Position around the chromosome is demarcated every 45 degrees and origin of replication and terminus are indicated in red. Note that strain D39V has a large inversion around the ter region compared to laboratory strain R6 (14) . B) Representation of insertion sequence upstream (ISU) and insertion sequence downstream (ISD) in pink for available PEP vectors. Double cross-over event leads to stable integration in CEP (pPEPX), CIL (pPEPY), or ZIP (pPEPZ) locus at indicated chromosomal locations based on most recent D39V genome annotation. requirements for 253 (5.03%) of S. pneumoniae strains tested. Other streptococcal species tested had no homology to the pPEPX vector that passed our requirements for a positive result. The pPEPY vector had 3,237 (64.37%) positive hits for S. pneumoniae, but no positive hits for other species tested. Similar results were found for the pPEPZ vector with 3,229 (64.21%) hits for S. pneumoniae and none for other species ( Figure  5 ). Based on our criteria above, all pneumococcal genomes queried can integrate at least one of the PEP vectors available.
Testing for transformation efficiency in numerous strains and species with multiple vectors is tedious and time consuming and testing a small portion of collected strains will not be as beneficial. Although competence for transformation is highly conserved in S. pneumoniae and most strains can be transformed in the laboratory, significant differences in transformation efficiencies of different strains are observed (36) . Through using sequencing data, it is possible to test thousands of strains for the presence of the integrative regions of the constructed plasmids. While this is not conclusive evidence for the ability of the PEP vectors to be transformable into queried strains, it is indicative that they are transformable. Through using stringent cut off conditions of at least 95% homology to the integration regions and the queried strains having 90% or more of the homology region, the chances of successful genomic integration are high. Supplementary Table 2 list all pneumococcal strains that passed our criteria and indicates possible transformability with the PEP vectors.
Efficient cloning in multidrug resistant clinical isolates using PEP vectors
Antibiotic resistance is on the rise and several clinically relevant strains are now commonly found worldwide, such as PMEN strains (37) . To determine the feasibility of using these plasmids in multi-drug resistant clinical isolates we tested the ability of PMEN strains 1, 3, 14, 18, 28 and TIGR4 to integrate PEP plasmids. These are serotype 23F, 9V, 19F, 14, 1, and 4 respectively and have different antibiotic susceptibilities. Table  2 summarizes the strains, susceptibility, transformability based on sequence and experimentally. All strains passed our transformability requirements based on genome sequence for at least one PEP vector. Supplementary figures 2, 3, and 4 demonstrate the homology of the integration regions of the PEP plasmids for several clinically relevant and antibiotic resistant strains. Experimentally determined transformability with the PEP vectors verified the feasibility of using a strains' genome sequence to indicate the ability to integrate a PEP vector. Even when we did not find a high level of homology, we could still transform strains PMEN3 and PMEN14 with plasmids pPEPX and pPEPY. The exception was for the pPEPY vector, which did not yield any transformants with PMEN18 or TIGR4 despite have high sequence homology to the integration region.
Discussion
Here we describe the creation and testing of three integration vectors for use in Streptococcus pneumoniae. These vectors can be used for a wide range of applications in the pneumococcal field; from complementation of gene deletions, labeling and expression of genes of interest, and/or expressing non-native proteins. The ability to efficiently transform and express any gene of interest stably from the chromosome as a single copy from a neutral locus is an essential tool for pneumococcal research. The PEP vectors described here can potentially be used in a large portion of pneumococcal strains and be of benefit to many researchers in the pneumococcal field. All described vectors are made available through Addgene (catalog numbers pending). It is our hope that making these vectors available will facilitate the research of other groups expanding our knowledge base of S. pneumoniae.
Materials and Methods
Growth Conditions
All pneumococcal strains are derived from the parent strain D39V (14) and were grown in the semi-synthetic media C + Y formulation 2018 (15) under selection conditions where applicable, see Table 1 . Standard pneumococcal transformation (16) protocols using synthetic CSP were used for strain construction with selection on Columbia agar supplemented with 2% sheep blood and appropriate antibiotics. Plasmids were cloned and maintained in Escherichia coli strains XL1-Blue or Stbl3 with LB media and selected on LB agar plates with appropriate antibiotics ( Table 1) . Transformation into E. coli was done using rubidium chloride chemically competent cells with standard procedures. Induction of all strains containing an IPTG-inducible promoter were activated with 1 mM of IPTG for 1 hour before visualization by microscopy.
Plasmid Construction
RNA-seq data available at https://veeninglab.com/pneumoexpress (13) and gene annotation data at https://veeninglab.com/pneumobrowse (14) was used for selection of transcriptionally silent regions. pPEPX-This vector is a modified smaller version of pPEP1 (12) lacking the chloramphenicol resistance marker and containing the high copy number origin of replication from pUC18, but still integrates at the neutral CEP locus near amiF (11) . The pUC18 origin of replication was amplified from pLA01 (17) using primers pUC18-F-KpnI and pUC18-R-NotI. The amplified fragment containing pUC18 origin and pPEP1 were digested with KpnI and NotI (NEB) for 1 hr at 37°C followed by overnight RT ligation with T4 DNA ligase (ThermoScientific). The resulting plasmid was then digested with KpnI and NcoI (NEB) for 1 hr at 37°C and ligated with hybridized primers NcoI-KpnI-link-F and NcoI-KpnI-link-R that were similarly digested. The IPTG inducible promoter was added to the promoterless pPEPX plasmid by digestion of pPEP8PL8-2 (18) with EcoRI and BglII and ligating appropriate fragment to complementary digested pPEPX. pPEPY-Creation of plasmid was completed through Gibson Assembly (NEB) using a minimum of 20 bp overlapping regions of five DNA fragments following manufacturers protocol. Integration regions were amplified from D39V genomic DNA using primer pairs LK042/LK043 and LK046/LK047. Origin of replication and multiple cloning site was amplified from pPEPX vector using primer pairs LK044/LK045 and LK040/LK041 respectively. Kanamycin resistance cassette was amplified from plasmid pDG783 (19) with primer pair LK033/LK034 that included addition of the PF6 promoter (12) for kanamycin expression. Three terminators were added to this vector through Gibson assembly of terminators from plasmid pJWV100 (7) (OVL68/69) and the pre-pPEPY plasmid (OVL66/67), creating pPEPY. The IPTG inducible promoter (Plac) (20) was added through restriction digestion of Plac amplified from FtsK-mNeonGreen (van Raaphorst and Veening, unpublished) with primer pair OVL64/65, creating pPEPY-Plac. Plasmid and DNA was digested with NheI and EcoRI followed by ligation and transformation into E. coli strain XL1-Blue. The pPEPY plasmid integrates at chromosomal integration locus (CIL) thereby interrupting the non-essential psuedogene spv_2165. pPEPZ-Creation of an integration vector of S. pneumoniae at the locus spv_2417 (aka spd_1735) was completed through Golden Gate cloning. Primers were designed with Benchling to amplify four different DNA fragments. Primer pairs OVL681/682 and OVL683/684 were used to amplify the downstream and upstream homologous region, respectively, for integration into S. pneumoniae by using chromosomal DNA of D39V as Table 2 : Spec-spectinomycin, Kan-Kanamycin, Gent-Gentamycin, Erm-Erythromycin, Tmp-Trimethoprim. *-pPEPZ plasmid chosen based on susceptibility of strain Table 1 : Spec-spectinomycin, Kan-Kanamycin, Gent-Gentamycin, Erm-Erythromycin, Amp-Ampicillin. Tmp-Trimethoprim template. Primers OVL685/686 were used to amplify the pUC18 origin of replication of from pPEPX vector and primers OVL687/688 were used to amplify a fragment containing the promoter Plac, the multiple cloning site, and the spectinomycin marker from the pPEP1-Plac vector (12) . DpnI treatment was performed for 15 min at 37°C and the four different amplified parts were purified and then digested with BsmBI (NEB) enzyme at 55˚C for 1.5 hrs. This reaction was purified and ligated at RT for 1.5 hrs then transformed into E. coli XL1-Blue. Digestion control followed by sequencing was performed to confirm the construct. The pPEPZ integrates at the PEPZ Integration Position (ZIP) locus upstream of spv_1736 thereby interrupting the non-essential pseudogene spv_2417. To generate the pPEPZ variants with gentamicin (gent) resistance, a Golden Gate strategy was employed. Primer pair OVL1066/1067 was used to amplify pPEPZ-Plac and primers pair OVL1068/1069 was used to amplify the gent gene from D39V containing the lacI gene at the prs1 locus as template (20) . The two PCR products were purified, digested with BbsI-HF (NEB) at 37˚C for 1 hr, and ligated at RT for 1 hr. Ligation mixture was transformed in E. coli strain Stbl3, sequencing was performed to confirm the construct called pASR102. pPEPZ containing bla-First, beta-lactamase gene (bla) was cloned into the pPEPZ-Plac (spec) vector in addition to the spectinomycin (spec) marker. Primer pairs OVL1190/1191 was used to amplified the bla gene from pASR113 as template (a pLA18 derivative, Rueff and Veening unpublished, (17) ). The purified PCR fragment and pPEPZ-Plac vector, were digested for 1.5 hrs at 37˚C with NotI (NEB) to introduce the bla gene at the unique NotI site of pPEPZ-Plac (spec), between the origin of replication of pUC18 and the upstream homologous region. Fragments were ligated at RT for 2 hrs and transformed into E. coli strain Stbl3 to generate intermediate plasmid pASR101. Second, this plasmid was used for resistance marker exchange of spectinomycin marker with an erythromycin (erm) marker by Golden Gate cloning. For that, pASR101 was amplified by PCR with OVL1066 and OVL1067, and the erm gene was amplified with OVL1070 and OVL1071 from strain XL39 (Liu and Veening unpublished) as template. The two PCR products were treated with DpnI (NEB) for 30 min at 37 ˚C, followed by purification and then digested with BbsI-HF (NEB) enzyme for 1 h at 37˚C. Reaction was purified and ligated for 30 min at room temperature followed by transformation in E. coli strain Stbl3. Sequencing was performed to confirm the construct called pASR103. Sequencing revealed an insertion between the erm marker and the Plac region. This insertion of 777 bp is from E. coli chromosomal DNA and does not affect the functioning of the plasmid, as the Plac promoter is still well insulated by the transcriptional terminators, but does increase plasmid size. Another version of the pPEPZ plasmid has been generated by replacing the erm marker with a trimethoprim (tmp) antibiotic marker. The plasmid was obtained by Golden Gate cloning as follows: primers OVL1696/1697 were used to amplify pASR103 and then DpnI (NEB) treated for 1 hr at 37˚C. Primers OVL1698/1699 were used to amplify the tmp gene from pneumococcal strain AM39 (21) as template. Thereafter, the two PCR products were purified and then digested with AarI (NEB) enzyme at 37˚C for 5 hrs. After purification, the two parts were ligated at RT for 2 hrs. The ligation mixture was used to transform E. coli strain Stbl3, and subsequent sequencing was performed to confirm the construct called pASR130. This plasmid also contains the E. coli chromosomal DNA insertion of 777 bp in between tmp and Plac promoter region, since it is based on the pASR103 plasmid. All plasmids were verified by sequencing and deposited at Addgene (pending accession number). Three additional pPEPY-Plac plasmids were created for carboxy(C)terminal fusions of three spectrally distinct fluorescent proteins, mTurquoise2 (22) , mNeonGreen (23) , and mScarlet-I (24) . The plasmid pPEPY-Plac-link-mNeonGreen was created through amplification of mNeonGreen containing an 11 amino acid C-terminal linker with primers link-mNG-F and link-mNG-R from plasmid pRRneon, which contains a S. pneumoniae codon optimized version of mNeonGreen (Raaphorst and Veening, unpublished). The resulting fragment was digested with BamHI and XhoI (NEB) for 1 hr at 37°C followed by overnight RT ligation with similarly digested pPEPY-Plac plasmid and T4 DNA ligase (ThermoScientific). The resulting plasmid was used for the template for pPEPY-Plac-link-mTurquoise2 using primers OVL914/915. mTurquoise2 was amplified with OVL916/917 using Addgene plasmid #54844 (mTurquoise2-pBAD) as template. Subsequent DNA fragments were digested in a single reaction with BsmBI (NEB) for 1 hr at 55°C followed by overnight ligation at RT with T4 DNA ligase (ThermoScientific). The mScarlet gene was obtained through S. pneumoniae codon optimized gene synthesis by IDT followed by cloning into pPEPY-Plac. The mScarlet-I variant was made through rPCR of pPEPY-Plac-mScarlet with primers OVL419/420 introducing a T73I point mutation to the protein. Subsequent amplification was digested with DpnI (NEB) for 1 hr at 37°C followed by treatment with ClonExpress (Vazyme) following manufacturers protocol.
The mScarlet-I variant was amplified from the resulting plasmid with OVL908/909 and combined with linearized pPEPY-Plac-Link (OVL906/907) and treated as for pPEPY-Plac-link-mTurquoise2 creation. All ligation products were subsequently cloned into XL1-Blue and verified by sequencing. Addgene is pending accession number. Gene fusions for ectopic integration at various PEP loci were created as follows. The fusion containing ComEA and mTurquoise2 was created through comEA amplification from D39V gDNA with primers OVL576/615. Amplification was digested with EcoRI and BamHI (NEB) for 1 hr at 37°C and ligated with similarly digested pPEPY-Plac-Link-mTurquoise2 followed by overnight ligation at RT with T4 DNA ligase (ThermoScientific). The HlpA and mNeonGreen fusion in pASR103, pPEPZ plasmid with erythromycin selection in S. pneumoniae, was created by hlpA-mNeonGreen amplification from strain VL1978 (Veening, unpublished) with primers OVL1569/1570. The resulting fragment and pASR103 were digested with BglII and XhoI (NEB) for 1 hr at 37°C followed by overnight ligation at RT with T4 DNA ligase. Creation of CEP locus integration of spv_1159-mScarlet-I was created through amplification of VL1785 gDNA, which contains CEP integration with a spv_1159-sfGFP fusion, (Kurushima and Veening unpublished) with primer pairs OVL037/869 and OVL040/870. The fragment containing mScarlet-I was amplified from plasmid pPEPY-Plac-Link-mScarlet-I with primer pair OVL871/872. The resulting three fragments were digested together with BsmBI (NEB) for 1 hr at 55°C followed by overnight ligation at RT with T4 DNA ligase. All oligos are listed in Supplementary Table 1 .
Strain Construction
Parental strain D39V was transformed with a constitutively expressed LacI under gentamycin selection, downstream of the prs1 locus (20) , leading to strain VL236. This strain was used for all future transformations, with the exception of plasmid pASR102, which was transformed into D39V, due to gentamycin selection of the plasmid. Standard pneumococcal transformation procedure was used to integrate all plasmids independently with appropriate selection (16) . For the strain expressing all plasmids (strain VL2706), each ligation product was sequentially cloned with verification of appropriate integration between each transformation.
Database BLAST
Local BLAST was done using NCBI blast-2.7.1+ against whole genomes with a minimum assembly at the contig level. All available S. pneumoniae sequences were downloaded from the NCBI database and combined with the Maela database (5,029 strains). Genomes of closely related species S. pseudopneumoniae (38 strains) and S. tigurinus (19 strains) as well as other streptococcal species S. mutans (190 strains), S. equi (259 strains), S. pyogenes (449 strains), and S. suis (1,261 strains) were downloaded from the NCBI database. Integration regions were used as the query sequences against BLAST databases. Results were filtered to include matches with over 95% sequence homology as well as containing at least 90% of the queried DNA. Duplicate matches were removed and results of both integration regions per plasmid were combined. A positive match was only identified if the combined filtered results included two hits per strain, one for upstream integration region and one for downstream integration region. Genetic circular map and comparative alignments were generated using GenomeMatcher and arcWithColor software with modification in graphic representation (25) .
Transformation Assay
Wild type S. pneumoniae strain D39V was grown to OD600 0.1, washed and suspended in pre-warmed non-acidic C+Y media. Competence was activated with 50 ng/ml of CSP-1 at 37˚C for 10 min and 45 µl was added to a 96 well plate. Five microliters of DNA was added at various concentrations as indicated and incubated for 120 min at 37˚C. Samples were serially diluted and plated on non-selective BA and BA with the appropriate antibiotics. Transformation efficiency was calculated by taking the difference between the CFU of the non-selective and the selective BA. For transformation of strains other than D39V, the above protocol was followed with the addition of 50 ng/ml of CSP-2 for initial competence activation due to variations in ComD specificity.
Microscopy
Fluorescence microscopy was performed on a Leica DMi8 through a 100x phase contrast objective (NA 1.40) with a SOLA Light Engine (lumencor) light source. Light was filtered through external excitation filters 430/24 nm (Chroma ET430/24x), 470/40 nm (Chroma ET470/40x), and 545/25 nm (Chroma ET545/25x) for visualization of mTurquoise2, mNeonGreen, or mScarlet-I respectively. For mTurquoise2, light passed through a cube (Leica 11536022) containing a polychroic mirror 455/520/595 nm while mNeonGreen and mScarlet-I used a cube (Leica 11536022) with a GFP/RFP polychroic mirror (498/564 nm). External emission filters used were from Chroma and ET470/24m, ET520/40m and ET605/70m were used for mTurquoise2, mNeonGreen and mScarlet-I, respectively. Exposure times of 700 ms, 200 ms, and 500 ms with 100% of light from SOLA Light Engine were performed for mTurquoise2, mNeonGreen, and mScarlet-I fusions respectively. Note that we also routinely image mNeonGreen through YFP filters (Chroma ET500/20x for excitation, Chroma ET535/30m for emission with a CFP/YFP/mCherry (455/520/595) polychroic mirror) in case there is signal bleed-through from the mTurquoise2 label in the GFP channel. Images were captured using LasX software (Leica) and exported to ImageJ (26) for final preparation.
